UK-based medical device company that specialises in the early detection of skin cancers
AMLo Biosciences has raised €2.9M across 1 funding round from 5 investors, most recently a round in Apr 2022. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-21 | Other |
| €2.9M |
| Ascension’s Life Fund,Conduit’s EIS Impact Fund,Esperante,Future Planet Capital’s BIF Opportunities Fund,Northstar Ventures |
| View deal → |
